You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy

Article metrics

Article menu

Download PDFPDF

Research Article
Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019330
Jan 2020661
Feb 2020551
Mar 202014141
Apr 202018182
May 202018182
Jun 2020992
Jul 202016162
Aug 202010100
Sep 202028282
Oct 202023244
Nov 202018172
Dec 202011101
Jan 202110100
Feb 2021662
Mar 202115152
Apr 2021884
May 2021886
Jun 202114142
Jul 202114141
Aug 202111112
Sep 202127274
Oct 202113133
Nov 202116165
Dec 202113131
Jan 202217196
Feb 202211112
Mar 202222242
Apr 202226285
May 202229293
Jun 202224243
Jul 202226274
Aug 202228282
Sep 202220200
Oct 202220201
Nov 2022131512
Dec 202210101
Jan 202318181
Feb 202327271
Mar 202310114
Apr 2023785
May 202311113
Jun 202325251
Jul 202326263
Aug 202338383
Sep 202317172
Oct 202360607
Nov 20231991990
Dec 202329292
Jan 202427285
Feb 2024353512
Mar 202416169
Apr 2024373812
May 202420203
Jun 202449487
Jul 202448494
Aug 202422207
Sep 2024202110
Oct 202418188
Nov 2024272812
Dec 2024343415
Jan 202529297
Feb 202523237
Mar 202530318
Apr 2025464613
May 2025323322
Jun 202519194
Jul 2025110
Sep 2025110
Feb 2026110
Total15821596290